Skip to main content
SpringerLink
Log in
Book cover

A Practical Guide to Skin Cancer pp 35–68Cite as

Basal Cell Carcinoma

  • Chapter
  • First Online:

  • 1439 Accesses

Abstract

Basal cell carcinoma (BCC) is the most common cancer in the United States. BCC is categorized by its clinical appearance and histology. The tumor subtype, anatomical location and patient’s health are factored into the treatment choice. Multiple treatment options exist with varying efficacy. Post-treatment, patient monitoring is important for possible recurrence and for the development of new skin cancers.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Verkouteren JA, et al. Epidemiology of basal cell carcinoma: scholarly review. Br J Dermatol. 2017;177:359.

    Article  PubMed  CAS  Google Scholar 

  2. Wysong A, Aasi SZ, Tang JY. Update on metastatic basal cell carcinoma: a summary of published cases from 1981 through 2011. JAMA Dermatol. 2013;149(5):615–6.

    Article  PubMed  Google Scholar 

  3. Zhang Y, et al. Body mass index, height and early-onset basal cell carcinoma in a case-control study. Cancer Epidemiol. 2017;46:66–72.

    Article  PubMed  Google Scholar 

  4. Wu S, et al. Cumulative ultraviolet radiation flux in adulthood and risk of incident skin cancers in women. Br J Cancer. 2014;110(7):1855–61.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Cockerell CJ, Tan KT, Carucci J, Tierney E, Lang P, Maize JC Sr, Rigel D. Basal cell carcinoma. In: Cancer of the skin. Edinburgh: Elsevier Inc; 2011. p. 99–123.

    Chapter  Google Scholar 

  6. Wang GY, et al. Differing tumor-suppressor functions of Arf and p53 in murine basal cell carcinoma initiation and progression. Oncogene. 2017;36(26):3772–80.

    Article  PubMed  CAS  Google Scholar 

  7. Chaudhary SC, et al. Naproxen inhibits UVB-induced basal cell and squamous cell carcinoma development in Ptch1+/− /SKH-1 hairless mice. Photochem Photobiol. 2017;93:1016.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  8. Fan Z, et al. A missense mutation in PTCH2 underlies dominantly inherited NBCCS in a Chinese family. J Med Genet. 2008;45(5):303–8.

    Article  PubMed  CAS  Google Scholar 

  9. Kijima C, et al. Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutation. Familial Cancer. 2012;11(4):565–70.

    Article  PubMed  Google Scholar 

  10. Scheinfeld N, et al. Identification of a recurrent mutation in the CYLD gene in Brooke-Spiegler syndrome. Clin Exp Dermatol. 2003;28(5):539–41.

    Article  PubMed  CAS  Google Scholar 

  11. Berlin NL, et al. Family history of skin cancer is associated with early-onset basal cell carcinoma independent of MC1R genotype. Cancer Epidemiol. 2015;39(6):1078–83.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Levine JA, et al. The indoor UV tanning industry: a review of skin cancer risk, health benefit claims, and regulation. J Am Acad Dermatol. 2005;53(6):1038–44.

    Article  PubMed  Google Scholar 

  13. Narala S, Cohen PR. Basal cell carcinoma of the umbilicus: a comprehensive literature review. Cureus. 2016;8(9):e770.

    PubMed  PubMed Central  Google Scholar 

  14. Loh TY, Rubin AG, Jiang SI. Basal cell carcinoma of the dorsal foot: an update and comprehensive review of the literature. Dermatol Surg. 2017;43(1):32–9.

    Article  PubMed  CAS  Google Scholar 

  15. Alsaedi M, Shoimer I, Kurwa HA. Basal cell carcinoma of the nipple-areola complex. Dermatol Surg. 2017;43(1):142–6.

    Article  PubMed  CAS  Google Scholar 

  16. Watson GA, et al. An unusual case of basal cell carcinoma of the vulva with lung metastases. Gynecol Oncol Rep. 2016;18:32–5.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  17. Loh T, Rubin AG, Brian Jiang SI. Management of mucosal basal cell carcinoma of the lip: an update and comprehensive review of the literature. Dermatol Surg. 2016;42(12):1313–9.

    Article  PubMed  CAS  Google Scholar 

  18. Hone NL, Grandhi R, Ingraffea AA. Basal cell carcinoma on the sole: an easily missed cancer. Case Rep Dermatol. 2016;8(3):283–6.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Hoashi T, et al. A case of penile basal cell carcinoma reconstructed by scrotal myofasciocutaneous flap. Dermatol Ther. 2016;29(5):349–52.

    Article  PubMed  Google Scholar 

  20. Hernandez-Aragues I, Baniandres-Rodriguez O. Basal cell carcinoma of the scrotum. Actas Urol Esp. 2016;40(9):592–3.

    Article  PubMed  CAS  Google Scholar 

  21. Buljan M, et al. Variations in clinical presentation of basal cell carcinoma. Acta Clin Croat. 2008;47(1):25–30.

    PubMed  Google Scholar 

  22. Sarkar S, et al. Neglected basal cell carcinoma on scalp. Indian J Dermatol. 2016;61(1):85–7.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Mehta KS, et al. Metastatic Basal cell carcinoma: a biological continuum of Basal cell carcinoma? Case Rep Dermatol Med. 2012;2012:157187.

    PubMed  PubMed Central  Google Scholar 

  24. Brodell RT, Wagamon K. The persistent nonhealing ulcer. Could it be basal cell carcinoma? Postgrad Med. 2001;109(1):29–32.

    Article  PubMed  CAS  Google Scholar 

  25. Lim KR, et al. Basal cell carcinoma presenting as a hypertrophic scar. Arch Plast Surg. 2013;40(3):289–91.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Nadiminti U, Rakkhit T, Washington C. Morpheaform basal cell carcinoma in African Americans. Dermatol Surg. 2004;30(12 Pt 2):1550–2.

    PubMed  Google Scholar 

  27. Park JY, et al. A rare dermoscopic pattern of nodular basal cell carcinoma with amyloid deposition. J Am Acad Dermatol. 2017;76(2s1):S55–6.

    Article  PubMed  Google Scholar 

  28. Diluvio L, Bavetta M, Di Prete M, Orlandi A, Bianchi L, and Campione E. Dermoscopic monitoring of efficacy of ingenol mebutate in the treatment of pigmented and non-pigmented basal cell carcinomas. Dermatologic Therapy 2017;30:e12438. doi:10.1111/dth.12438. (electronic publication)

    Article  Google Scholar 

  29. Arpaia N, et al. Vascular patterns in cutaneous ulcerated basal cell carcinoma: a retrospective blinded study including dermoscopy. Acta Derm Venereol. 2017;97:612.

    Article  PubMed  Google Scholar 

  30. Hirofuji A, et al. Superficial type of multiple basal cell carcinomas: detailed comparative study of its dermoscopic and histopathological findings. J Skin Cancer. 2011;2011:385465.

    Article  PubMed  Google Scholar 

  31. Mary Nolen VB, King J, Bryn N, Morin LK. Nonmelanoma skin cancer: part 1. J Dermatol Nurses Assoc. 2011;3(5):260–81.

    Article  Google Scholar 

  32. Yoneta A, et al. A case of cystic basal cell carcinoma which shows a homogenous blue/black area under Dermatoscopy. J Skin Cancer. 2011;2011:450472.

    Article  PubMed  Google Scholar 

  33. Lima NL, et al. Basosquamous carcinoma: histopathological features. Indian J Dermatol. 2012;57(5):382–3.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Akay BN, et al. Basosquamous carcinoma: dermoscopic clues to diagnosis. J Dermatol. 2016;44:127–134

    Article  PubMed  CAS  Google Scholar 

  35. Tan CZ, Rieger KE, Sarin KY. Basosquamous carcinoma: controversy, advances, and future directions. Dermatol Surg. 2017;43(1):23–31.

    Article  PubMed  CAS  Google Scholar 

  36. Tchernev G, et al. Multiple nonsyndromic acquired basal cell carcinomas : Uncommon clinical presentation in a Bulgarian patient. Wien Med Wochenschr. 2017;167:134.

    Article  PubMed  Google Scholar 

  37. Hendrix JD Jr, Parlette HL. Duplicitous growth of infiltrative basal cell carcinoma: analysis of clinically undetected tumor extent in a paired case-control study. Dermatol Surg. 1996;22(6):535–9.

    Article  PubMed  Google Scholar 

  38. Coleman CI, Wine-Lee L, James WD. Pigmented basal cell carcinoma: uncommon presentation in blue-eyed patients. JAMA Dermatol. 2013;149(8):995–6.

    Article  PubMed  Google Scholar 

  39. Alcantara-Reifs CM, et al. Linear basal cell carcinoma: report of three cases with dermoscopic findings. Indian J Dermatol Venereol Leprol. 2016;82(6):708–11.

    Article  PubMed  Google Scholar 

  40. Yamaguchi Y, et al. A case of linear basal cell carcinoma: evaluation of proliferative activity by immunohistochemical staining of PCTAIRE1 and p27. J Eur Acad Dermatol Venereol. 2017;31:e359.

    Article  PubMed  CAS  Google Scholar 

  41. Yazdani Abyaneh MA, et al. Giant basal cell carcinomas express neuroactive mediators and show a high growth rate: a case-control study and meta-analysis of etiopathogenic and prognostic factors. Am J Dermatopathol. 2017;39(3):189–94.

    Article  PubMed  Google Scholar 

  42. Bellahammou K, et al. Metastatic giant basal cell carcinoma: a case report. Pan Afr Med J. 2016;24:157.

    PubMed  PubMed Central  Google Scholar 

  43. Kornreich DA, Lee JB. White network in fibroepithelioma of Pinkus. JAAD Case Rep. 2016;2(5):400–2.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Gomez-Martin I, et al. Pigmented fibroepithelioma of Pinkus: a potential dermoscopic simulator of malignant melanoma. J Dermatol. 2017;44(5):542–3.

    Article  PubMed  Google Scholar 

  45. Dongre AM, et al. Fibroepithelioma of Pinkus in continuity with nodular basal cell carcinoma: a rare presentation. Indian Dermatol Online J. 2016;7(4):285–7.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Crowson AN. Basal cell carcinoma: biology, morphology and clinical implications. Mod Pathol. 2006;19(Suppl 2):S127–47.

    Article  PubMed  Google Scholar 

  47. Saxena K, et al. Adenoid basal cell carcinoma: a rare facet of basal cell carcinoma. BMJ Case Rep. 2016;2016. https://doi.org/10.1136/bcr-2015-214166.

  48. Murkey N, et al. Adenoid variant of basal cell carcinoma: a case report with a glance at biological behavior of the tumor. Indian J Dermatol. 2017;62(1):103–5.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Anjum N, et al. Follicular proliferation or basal cell carcinoma? The first prospective UK study of this histological challenge during Mohs Surgery. Br J Dermatol. 2017;177(2):549–50.

    Article  PubMed  CAS  Google Scholar 

  50. Viera M, et al. A new look at fibroepithelioma of pinkus: features on confocal microscopy. J Clin Aesthet Dermatol. 2008;1(2):42–4.

    PubMed  PubMed Central  Google Scholar 

  51. Hasbun Acuna P, et al. Pigmented basal cell carcinoma mimicking a superficial spreading melanoma. Medwave. 2016;16(11):e6805.

    Article  PubMed  Google Scholar 

  52. Nagi R, Sahu S, Agarwal N. Unusual presentation of pigmented basal cell carcinoma of face: surgical challenge. J Clin Diagn Res. 2016;10(7):Zj06–7.

    PubMed  PubMed Central  CAS  Google Scholar 

  53. Christian MM, et al. A correlation of alpha-smooth muscle actin and invasion in micronodular basal cell carcinoma. Dermatol Surg. 2001;27(5):441–5.

    PubMed  CAS  Google Scholar 

  54. Bard RL. High-frequency ultrasound examination in the diagnosis of skin cancer. Dermatol Clin. 2017;35(4):505–11.

    Article  PubMed  CAS  Google Scholar 

  55. Hong H, Sun J, Cai W. Anatomical and molecular imaging of skin cancer. Clin Cosmet Investig Dermatol. 2008;1:1–17.

    PubMed  PubMed Central  CAS  Google Scholar 

  56. Zeitouni NC, et al. Preoperative ultrasound and photoacoustic imaging of nonmelanoma skin cancers. Dermatol Surg. 2015;41(4):525–8.

    Article  PubMed  CAS  Google Scholar 

  57. MacFarlane D, et al. The role of imaging in the management of patients with nonmelanoma skin cancer: diagnostic modalities and applications. J Am Acad Dermatol. 2017;76(4):579–88.

    Article  PubMed  Google Scholar 

  58. Belkin DA, Wysong A. Radiographic imaging for skin cancer. Semin Cutan Med Surg. 2016;35(1):42–8.

    Article  PubMed  Google Scholar 

  59. Humphreys TR, et al. The role of imaging in the management of patients with nonmelanoma skin cancer: when is imaging necessary? J Am Acad Dermatol. 2017;76(4):591–607.

    Article  PubMed  Google Scholar 

  60. Duncan JR, Carr D, Kaffenberger BH. The utility of positron emission tomography with and without computed tomography in patients with nonmelanoma skin cancer. J Am Acad Dermatol. 2016;75(1):186–96.

    Article  PubMed  Google Scholar 

  61. Lubeek SF, Arnold WP. A retrospective study on the effectiveness of curettage and electrodesiccation for clinically suspected primary nodular basal cell carcinoma. Br J Dermatol. 2016;175(5):1097–8.

    Article  PubMed  CAS  Google Scholar 

  62. Woldow AB, Melvin ME. Early detection of desiccation and curettage failure in the treatment of basal cell carcinoma. Dermatology. 2016;232:696.

    Article  PubMed  CAS  Google Scholar 

  63. Lara F, Santamaria JR, Garbers LE. Recurrence rate of basal cell carcinoma with positive histopathological margins and related risk factors. An Bras Dermatol. 2017;92(1):58–62.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Sexton M, Jones DB, Maloney ME. Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. J Am Acad Dermatol. 1990;23(6 Pt 1):1118–26.

    Article  PubMed  CAS  Google Scholar 

  65. Gulleth Y, et al. What is the best surgical margin for a basal cell carcinoma: a meta-analysis of the literature. Plast Reconstr Surg. 2010;126(4):1222–31.

    Article  PubMed  CAS  Google Scholar 

  66. Thomas DJ, King AR, Peat BG. Excision margins for nonmelanotic skin cancer. Plast Reconstr Surg. 2003;112(1):57–63.

    Article  PubMed  Google Scholar 

  67. Sin CW, Barua A, Cook A. Recurrence rates of periocular basal cell carcinoma following Mohs micrographic surgery: a retrospective study. Int J Dermatol. 2016;55(9):1044–7.

    Article  PubMed  Google Scholar 

  68. Wolfe CM, Cognetta AB Jr. Radiation therapy (RT) for nonmelanoma skin cancer (NMSC), a cost comparison: clarifying misconceptions. J Am Acad Dermatol. 2016;75(3):654–5.

    Article  PubMed  Google Scholar 

  69. McGregor S, Minni J, Herold D. Superficial radiation therapy for the treatment of nonmelanoma skin cancers. J Clin Aesthet Dermatol. 2015;8(12):12–4.

    PubMed  PubMed Central  Google Scholar 

  70. Duinkerken CW, et al. Orthovoltage X-rays for postoperative treatment of resected basal cell carcinoma in the head and neck area. J Cutan Med Surg. 2017;21(3):243–9. https://doi.org/10.1177/1203475416687268.

    Article  PubMed  Google Scholar 

  71. Vuong W, Lin J, Wei RL. Palliative radiotherapy for skin malignancies. Ann Palliat Med. 2017;6(2):165–72.

    Article  PubMed  Google Scholar 

  72. Piccinno R, et al. Dermatologic radiotherapy in the treatment of extensive basal cell carcinomas: a retrospective study. J Dermatolog Treat. 2017;28(5):1–5.

    Article  PubMed  CAS  Google Scholar 

  73. Avril MF, et al. Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer. 1997;76(1):100–6.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  74. Zouboulis CC. Cryosurgery in dermatology. Hautarzt. 2015;66(11):834–48.

    Article  PubMed  CAS  Google Scholar 

  75. Erratum. Could cryosurgery be an alternative treatment for basal cell carcinoma of the vulva?: Erratum. Indian Dermatol Online J. 2015;6(4):314.

    Article  Google Scholar 

  76. Har-Shai Y, et al. Intralesional cryosurgery for the treatment of basal cell carcinoma of the lower extremities in elderly subjects: a feasibility study. Int J Dermatol. 2016;55(3):342–50.

    Article  PubMed  Google Scholar 

  77. Weshahy AH, et al. The efficacy of intralesional cryosurgery in the treatment of small- and medium-sized basal cell carcinoma: a pilot study. J Dermatolog Treat. 2015;26(2):147–50.

    Article  PubMed  Google Scholar 

  78. Gaitanis G, Kalogeropoulos CD, Bassukas ID. Cryosurgery during Imiquimod (Immunocryosurgery) for periocular basal cell carcinomas: an efficacious minimally invasive treatment alternative. Dermatology. 2016;232(1):17–21.

    Article  PubMed  Google Scholar 

  79. Lanoue J, Goldenberg G. Basal cell carcinoma: a comprehensive review of existing and emerging nonsurgical therapies. J Clin Aesthet Dermatol. 2016;9(5):26–36.

    PubMed  PubMed Central  Google Scholar 

  80. Soleymani T, Abrouk M, Kelly KM. An analysis of laser therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg. 2017;43(5):615–24.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  81. Ortiz AE, Anderson RR, Avram MM. 1064 nm long-pulsed Nd:YAG laser treatment of basal cell carcinoma. Lasers Surg Med. 2015;47(2):106–10.

    Article  PubMed  Google Scholar 

  82. Konnikov N, et al. Pulsed dye laser as a novel non-surgical treatment for basal cell carcinomas: response and follow up 12-21 months after treatment. Lasers Surg Med. 2011;43(2):72–8.

    Article  PubMed  Google Scholar 

  83. Carija A, et al. Single treatment of low-risk basal cell carcinomas with pulsed dye laser-mediated photodynamic therapy (PDL-PDT) compared with photodynamic therapy (PDT): a controlled, investigator-blinded, intra-individual prospective study. Photodiagn Photodyn Ther. 2016;16:60–5.

    Article  Google Scholar 

  84. Kessels JP, et al. Ambulatory photodynamic therapy for superficial basal cell carcinoma: an effective light source? Acta Derm Venereol. 2017;97:649.

    Article  PubMed  Google Scholar 

  85. Karabulut GO, et al. Imiquimod 5% cream for the treatment of large nodular basal cell carcinoma at the medial canthal area. Indian J Ophthalmol. 2017;65(1):48–51.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Yang X, Dinehart MS. Triple hedgehog pathway inhibition for basal cell carcinoma. J Clin Aesthet Dermatol. 2017;10(4):47–9.

    PubMed  PubMed Central  Google Scholar 

  87. Williams HC, et al. Surgery versus 5% Imiquimod for nodular and superficial basal cell carcinoma: 5-year results of the SINS randomized controlled trial. J Invest Dermatol. 2017;137(3):614–9.

    Article  PubMed  CAS  Google Scholar 

  88. Singal A, et al. Facial basal cell carcinoma treated with topical 5% Imiquimod cream with Dermoscopic evaluation. J Cutan Aesthet Surg. 2016;9(2):122–5.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Urech M, et al. Dermoscopic ulceration is a predictor of basal cell carcinoma response to Imiquimod: a retrospective study. Acta Derm Venereol. 2017;97(1):117–9.

    Article  PubMed  Google Scholar 

  90. Jung YS, et al. Superficial basal cell carcinoma treated with two cycles of ingenol mebutate gel 0.015. Ann Dermatol. 2016;28(6):796–7.

    Article  PubMed  PubMed Central  Google Scholar 

  91. Izzi S, et al. Successfully treated superficial basal cell carcinomas with ingenol mebutate 0.05% gel: report of twenty cases. Dermatol Ther. 2016;29(6):470–2.

    Article  PubMed  CAS  Google Scholar 

  92. Bettencourt MS. Treatment of superficial basal cell carcinoma with ingenol mebutate gel, 0.05%. Clin Cosmet Investig Dermatol. 2016;9:205–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  93. Wong Y, Low JA, Chio MT. Role of topical tranexamic acid in hemostasis of locally advanced basal cell carcinoma. JAAD Case Rep. 2016;2(2):162–3.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Ker K, Beecher D, Roberts I. Topical application of tranexamic acid for the reduction of bleeding. Cochrane Database Syst Rev. 2013;(7):CD010562.

    Google Scholar 

  95. Micali G, et al. Topical pharmacotherapy for skin cancer: part I. Pharmacology. J Am Acad Dermatol. 2014;70(6):965.e1–12; quiz 977–8.

    Article  CAS  Google Scholar 

  96. Chang J, et al. Association between programmed death ligand 1 expression in patients with basal cell carcinomas and the number of treatment modalities. JAMA Dermatol. 2017;153:285.

    Article  PubMed  Google Scholar 

  97. Chen L, Silapunt S, Migden MR. Sonidegib for the treatment of advanced basal cell carcinoma: a comprehensive review of sonidegib and the BOLT trial with 12-month update. Future Oncol. 2016;12(18):2095–105.

    Article  PubMed  CAS  Google Scholar 

  98. Cox KF, Margo CE. Role of vismodegib in the management of advanced periocular basal cell carcinoma. Cancer Control. 2016;23(2):133–9.

    Article  PubMed  Google Scholar 

  99. Falchook GS, et al. Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810. J Immunother Cancer. 2016;4:70.

    Article  PubMed  PubMed Central  Google Scholar 

  100. Lacouture ME, et al. Characterization and management of hedgehog pathway inhibitor-related adverse events in patients with advanced basal cell carcinoma. Oncologist. 2016;21(10):1218–29.

    Article  PubMed  PubMed Central  Google Scholar 

  101. McGrane J, Carswell S, Talbot T. Metastatic spinal cord compression from basal cell carcinoma of the skin treated with surgical decompression and vismodegib: case report and review of hedgehog signalling pathway inhibition in advanced basal cell carcinoma. Clin Exp Dermatol. 2017;42(1):80–3.

    Article  PubMed  CAS  Google Scholar 

  102. Fife D, et al. Vismodegib therapy for basal cell carcinoma in an 8-year-old Chinese boy with xeroderma pigmentosum. Pediatr Dermatol. 2017;34(2):163–5.

    Article  PubMed  Google Scholar 

  103. Fife K, et al. Managing adverse events associated with vismodegib in the treatment of basal cell carcinoma. Future Oncol. 2017;13(2):175–84.

    Article  PubMed  CAS  Google Scholar 

  104. Guo D, Kossintseva I, Leitenberger J. Neoadjuvant vismodegib before Mohs: lack of tissue sparing and squamous differentiation of basal cell carcinoma in a patient with chronic lymphocytic leukemia. Dermatol Surg. 2016;42(6):780–3.

    Article  PubMed  CAS  Google Scholar 

  105. Kwon GP, et al. Update to an open-label clinical trial of vismodegib as neoadjuvant before surgery for high-risk basal cell carcinoma (BCC). J Am Acad Dermatol. 2016;75(1):213–5.

    Article  PubMed  Google Scholar 

  106. Lima JP. Statistical concerns on vismodegib for basal cell carcinoma meta-analysis. JAMA Dermatol. 2017;153:337.

    Article  PubMed  Google Scholar 

  107. Paulsen JF, et al. Vismodegib and surgery combined – effective treatment of locally advanced basal cell carcinoma. Acta Oncol. 2016;55(12):1492–4.

    Article  PubMed  Google Scholar 

  108. Casey D, et al. FDA approval summary: sonidegib for locally advanced basal cell carcinoma. Clin Cancer Res. 2017;23:2377.

    Article  PubMed  CAS  Google Scholar 

  109. Tibes R. Sonidegib phosphate: new approval for basal cell carcinoma. Drugs Today (Barc). 2016;52(5):295–303.

    Article  CAS  Google Scholar 

  110. Yin VT, Esmaeli B. Targeting the hedgehog pathway for locally advanced and metastatic basal cell carcinoma. Curr Pharm Des. 2017;23(4):655–9.

    Article  PubMed  CAS  Google Scholar 

  111. Silapunt S, Chen L, Migden MR. Hedgehog pathway inhibition in advanced basal cell carcinoma: latest evidence and clinical usefulness. Ther Adv Med Oncol. 2016;8(5):375–82.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  112. Ramelyte E, Amann VC, Dummer R. Sonidegib for the treatment of advanced basal cell carcinoma. Expert Opin Pharmacother. 2016;17(14):1963–8.

    Article  PubMed  CAS  Google Scholar 

  113. Collier NJ, Ali FR, Lear JT. The safety and efficacy of sonidegib for the treatment of locally advanced basal cell carcinoma. Expert Rev Anticancer Ther. 2016;16(10):1011–8.

    Article  PubMed  CAS  Google Scholar 

  114. Dreno B, et al. Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomised, regimen-controlled, double-blind, phase 2 trial. Lancet Oncol. 2017;18(3):404–12.

    Article  PubMed  CAS  Google Scholar 

  115. Yonjan Lama I, Wharton S. Comment Re: ‘Treatment of basal cell carcinoma with surgical excision and perilesional interferon-alpha’. J Plast Reconstr Aesthet Surg. 2015;68(6):877–8.

    Article  PubMed  Google Scholar 

  116. Wettstein R, et al. Treatment of basal cell carcinoma with surgical excision and perilesional interferon-alpha. J Plast Reconstr Aesthet Surg. 2013;66(7):912–6.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, University of Southern California, Los Angeles, CA, USA

    Shauna Higgins, Maggie Chow & Ashley Wysong

Authors
  1. Shauna Higgins
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maggie Chow
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ashley Wysong
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ashley Wysong .

Editor information

Editors and Affiliations

  1. Department of Medicine, Division of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee, USA

    Allison Hanlon

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Higgins, S., Chow, M., Wysong, A. (2018). Basal Cell Carcinoma. In: Hanlon, A. (eds) A Practical Guide to Skin Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-74903-7_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-74903-7_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-74901-3

  • Online ISBN: 978-3-319-74903-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation